Aventis Wants Sens.' Letter Excluded In Arava Case

Law360, New York (October 7, 2008, 12:00 AM EDT) -- Sanofi-Aventis U.S. LLC and Aventis Pharmaceuticals Inc. are asking the judge overseeing a lawsuit accusing them of blocking generic competition for arthritis drug Arava not to allow a 2006 letter penned by former U.S. Sen. Trett Lott and current Sen. Debbie Stabenow to be introduced at trial.

Aventis filed a motion in limine Monday in the U.S. District Court for the Southern District of New York seeking to exclude the letter. Aventis also filed four other motions — two of which are under seal — on...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.